The PE Ratio as of November 2024 (TTM) for Avenue Therapeutics, Inc. (ATXI) is 0.08

According to Avenue Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.08. This represents a change of -99.73% compared to the average of 29.99 of the last 4 quarters.

Avenue Therapeutics, Inc. (ATXI) Historical PE Ratio (quarterly & annually)

How has ATXI PE Ratio performed in the past?

The mean historical PE Ratio of Avenue Therapeutics, Inc. over the last ten years is -573.34. The current 0.08 PE Ratio has changed -101.40% with respect to the historical average. Over the past ten years (40 quarters), ATXI's PE Ratio was at its highest in in the September 2023 quarter at 204.51. The PE Ratio was at its lowest in in the September 2020 quarter at -3263.12.

Avenue Therapeutics, Inc. (ATXI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Avenue Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avenue Therapeutics, Inc. (ATXI) Average PE Ratio

How has ATXI PE Ratio performed in the past?

The current PE Ratio of Avenue Therapeutics, Inc. (ATXI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Avenue Therapeutics, Inc. (ATXI) PE Ratio vs. Peers

How is ATXI’s PE Ratio compared to its peers?

Avenue Therapeutics, Inc.’s PE Ratio is greater than Hoth Therapeutics, Inc. (-0.77), greater than Revelation Biosciences, Inc. (-0.13), greater than NeuroBo Pharmaceuticals, Inc. (-0.87), greater than Virax Biolabs Group Limited (-0.67), greater than Panbela Therapeutics, Inc. (-0.06), greater than Palisade Bio, Inc. (-0.26), greater than Quoin Pharmaceuticals, Ltd. (-0.33), greater than ContraFect Corporation (-0.19), greater than Allarity Therapeutics, Inc. (-0.10), greater than CNS Pharmaceuticals, Inc. (-0.16), greater than Windtree Therapeutics, Inc. (-0.03), less than Kiromic BioPharma, Inc. (0), greater than Biodexa Pharmaceuticals Plc (-1.34), greater than null (-0.18),

Build a custom stock screener for Avenue Therapeutics, Inc. (ATXI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avenue Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avenue Therapeutics, Inc. (ATXI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avenue Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.